Equities

Biostem Technologies Inc

BSEM:PKC

Biostem Technologies Inc

Actions
Consumer DiscretionaryConsumer Discretionary
  • Price (USD)10.04
  • Today's Change0.275 / 2.82%
  • Shares traded7.56k
  • 1 Year change+285.96%
  • Beta1.9024
Data delayed at least 15 minutes, as of Sep 19 2024 20:35 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Dec 31 2023202320212020
ASSETS
Cash And Short Term Investments0.240.340.10
Total Receivables, Net110.300.01
Total Inventory0.660.320.57
Prepaid expenses0.330.040.17
Other current assets, total--00
Total current assets131.000.85
Property, plant & equipment, net1.371.281.35
Goodwill, net0.240.240.47
Intangibles, net0.350.21--
Long term investments------
Note receivable - long term------
Other long term assets--00
Total assets152.742.67
LIABILITIES
Accounts payable------
Accrued expenses1.702.301.88
Notes payable/short-term debt03.600.23
Current portion long-term debt/capital leases4.450.033.90
Other current liabilities, total8.08--0.19
Total current liabilities156.736.80
Total long term debt0.271.411.50
Total debt4.725.035.63
Deferred income tax------
Minority interest00.170.17
Other liabilities, total0.0100
Total liabilities168.308.47
SHAREHOLDERS EQUITY
Common stock0.020.013.68
Additional paid-in capital442419
Retained earnings (accumulated deficit)(45)(29)(28)
Treasury stock - common(0.04)(0.04)(0.03)
Unrealized gain (loss)------
Other equity, total----(0.74)
Total equity(0.98)(5.57)(5.8)
Total liabilities & shareholders' equity152.742.67
Total common shares outstanding169.689.20
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.